Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696226 · ClinicalTrials.gov registry record · NA
Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02696226: Clinical Trial NA study, sponsored by The Cleveland Clinic.
NCT02696226 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02696226, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a prospective, randomized pilot study in patients undergoing Sugical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR) to estimate the incidence of reduced leaflet motion and assess the impact of perioperative anticoagulation on the incidence of reduced leaflet motion.
Primary Outcome
Frequency of reduced leaflet motion related to perioperative anticoagulation with warfarin as measured by 4DMCT data. (\<50% reduction in motion), moderately reduced (50 to 70% reduction), severely reduced (\>70% reduction), or immobile (lack of motion of at least one valve leaflet).
Interventions
- DRUG SAVR Warfarin
- DRUG SAVR Aspirin
- DRUG TAVR Warfarin and clopidogrel
- DRUG TAVR Aspirin and clopidogrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07-28 |
| Phase | NA |
Why NCT02696226 stopped before completion
NCT02696226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which SAVR Warfarin is the first listed.
NCT02696226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02696226 about?
NCT02696226 is a clinical study titled "Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.". This is a prospective, randomized pilot study in patients undergoing Sugical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR) to estimate the incidence of reduced leaflet motion and assess the impact of perioperative anticoagulation on the incidence of reduced leafle...
What is the current status of trial NCT02696226?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-02. Estimated completion is 2017-07-28.
What interventions are being tested in trial NCT02696226?
The interventions under investigation include: SAVR Warfarin (DRUG), SAVR Aspirin (DRUG), TAVR Warfarin and clopidogrel (DRUG), TAVR Aspirin and clopidogrel (DRUG).
Who is sponsoring clinical trial NCT02696226?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02696226's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia